Suite of DNA nanotechnology devices engineered to overcome specific bottlenecks in the development of new therapies, diagnostics, and understanding of molecular structures.
DNA nanostructures with their potential for cell and tissue permeability, biocompatibility, and high programmability at the nanoscale level are promising candidates as new types of drug delivery vehicles, highly specific diagnostic devices, and tools to decipher how biomolecules dynamically change their shapes, and interact with each other and with candidate drugs. Wyss Institute researchers are providing a suite of diverse, multifunctional DNA nanotechnological tools with unique capabilities and potential for a broad range of clinical and biomedical research areas.
DNA nanotechnological devices for therapeutic drug delivery
DNA nanostructures have future potential to be widely used to transport and present a variety of biologically active molecules such as drugs and immune-enhancing antigens and adjuvants to target cells and tissues in the human body.
DNA origami as high-precision delivery components of cancer vaccines
The Wyss Institute has developed cancer vaccines to improve immunotherapies. These approaches use implantable or injectable biomaterial-based scaffolds that present tumor-specific antigens, and biomolecules that attract dendritic immune cells (DCs) into the scaffold, and activate them so that after their release they can orchestrate anti-tumor T cell responses against tumors carrying the same antigens. To be activated most effectively, DCs likely need to experience tumor antigens and immune-boosting CpG adjuvant molecules at particular ratios (stoichiometries) and configurations that register with the density and distribution of receptor molecules on their cell surface.
Specifically developed DNA origami, programmed to assemble into rigid square-lattice blocks that co-present tumor antigens and adjuvants to DCs within biomaterial scaffolds with nanoscale precision have the potential to boost the efficacy of therapeutic cancer vaccines, and can be further functionalized with anti-cancer drugs.
Chemical modification strategy to protect drug-delivering DNA nanostructures
DNA nanostructures such as self-assembling DNA origami are promising vehicles for the delivery of drugs and diagnostics. They can be flexibly functionalized with small molecule and protein drugs, as well as features that facilitate their delivery to specific target cells and tissues. However, their potential is hampered by their limited stability in the body’s tissues and blood. To help fulfill the extraordinary promise of DNA nanostructures, Wyss researchers developed an easy, effective and scalable chemical cross-linking approach that can provide DNA nanostructures with the stability they need as effective vehicles for drugs and diagnostics.
![DNA Nanotechnology Tools: From Design to Applications](https://wyss-prod.imgix.net/app/uploads/2020/08/17151439/DNA-Nanostructure-with-PEG-oligolysines.jpg?w=25&h=14&auto=format&q=10&fit=crop&crop=faces%2Centropy&blur=75)
In two simple cost-effective steps, the Wyss’ approach first uses a small-molecule, unobtrusive neutralizing agent, PEG-oligolysine, that carries multiple positive charges, to cover DNA origami structures. In contrast to commonly used Mg2+ ions that each neutralize only two negative changes in DNA structures, PEG-oligolysine covers multiple negative charges at one, thus forming a stable “electrostatic net,” which increases the stability of DNA nanostructures about 400-fold. Then, by applying a chemical cross-linking reagent known as glutaraldehyde, additional stabilizing bonds are introduced into the electrostatic net, which increases the stability of DNA nanostructures by another 250-fold, extending their half-life into a range that is compatible with a broad range of clinical applications.
DNA nanotechnological devices as ultrasensitive diagnostic and analytical tools
The generation of detectable DNA nanostructures in response to a disease or pathogen-specific nucleic acids, in principle, offers a means for highly effective biomarker detection in diverse samples. A single molecule binding event of a synthetic oligonucleotide to a target nucleic acid can nucleate the creation of much larger structures by the cooperative assembly of smaller synthetic DNA units like DNA tiles or bricks into larger structures that then can be visualized in simple laboratory assays. However, a central obstacle to these approaches is the occurrence of (1) non-specific binding and (2) non-specific nucleation events in the absence of a specific target nucleic acid which can lead to false-positive results. Wyss DNA nanotechnologists have developed two separately applicable but combinable solutions for these problems.
Digital counting of biomarker molecules with DNA nanoswitch catenanes
To enable the initial detection (binding) of biomarkers with ultra-high sensitivity and specificity, Wyss researchers have developed a type of DNA nanoswitch that, designed as a larger catenane (Latin catena meaning chain), is assembled from mechanically interlocked ring-shaped substructures with specific functionalities that together enable the detection and counting of single biomarker molecules. In the “DNA Nanoswitch Catenane” structure, both ends of a longer synthetic DNA strand are linked to two antibody fragments that each specifically bind different parts of the same biomarker molecule of interest, thus allowing for high target specificity and sensitivity.
This bridging-event causes the strand to close into a “host ring,” which it is interlocked at different regions with different “guest rings.” Closing of the host ring switches the guest rings into a configuration that allows the synthesis of a new DNA strand. The newly synthesized diagnostic strand then can be unambiguously detected as a single digital molecule count, while disrupting the antibody fragment/biomarker complex starts a new biomarker counting cycle. Both, the target binding specificity and the synthesis of a target-specific DNA strand also enable the combination of multiple DNA nanoswitch catenanes to simultaneously count different biomarker molecules in a single multiplexed reaction.
For ultrasensitive diagnostics, it is desirable to have the fastest amplification and the lowest rate of spurious nucleation. DNA nanotechnology approaches have the potential to deliver this in an enzyme-free, low-cost manner.
A rapid amplification platform for diverse biomarkers
A rapid, low-cost and enzyme-free detection and amplification platform avoids non-specific nucleation and amplification and allows the self-assembly of much larger micron-scale structures from a single seed in just minutes. The method, called “Crisscross Nanoseed Detection” enables the ultra-cooperative assembly of ribbons starting from a single biomarker binding event. The micron-scale structures are densely woven from single-stranded “DNA slats,” whereby an inbound slat snakes over and under six or more previously captured slats on a growing ribbon end in a “crisscross” manner, forming weak but highly-specific interactions with its interacting DNA slats. The nucleation of the assembly process is strictly target-seed specific and the assembly can be carried out in a one-step reaction in about 15 minutes without the addition of further reagents, and over a broad range of temperatures. Using standard laboratory equipment, the assembled structures then can be rapidly visualized or otherwise detected, for example, using high-throughput fluorescence plate reader assays.
![](https://www.nanoappsmedical.com/wp-content/uploads/2017/05/spacer.jpg)
News
The Silent Battle Within: How Your Organs Choose Between Mom and Dad’s Genes
Research reveals that selective expression of maternal or paternal X chromosomes varies by organ, driven by cellular competition. A new study published today (July 26) in Nature Genetics by the Lymphoid Development Group at the MRC [...]
Study identifies genes increasing risk of severe COVID-19
Whether or not a person becomes seriously ill with COVID-19 depends, among other things, on genetic factors. With this in mind, researchers from the University Hospital Bonn (UKB) and the University of Bonn, in [...]
Small regions of the brain can take micro-naps while the rest of the brain is awake and vice versa
Sleep and wake: They're totally distinct states of being that define the boundaries of our daily lives. For years, scientists have measured the difference between these instinctual brain processes by observing brain waves, with [...]
Redefining Consciousness: Small Regions of the Brain Can Take Micro-Naps While the Rest of the Brain Is Awake
The study broadly reveals how fast brain waves, previously overlooked, establish fundamental patterns of sleep and wakefulness. Scientists have developed a new method to analyze sleep and wake states by detecting ultra-fast neuronal activity [...]
AI Reveals Health Secrets Through Facial Temperature Mapping
Researchers have found that different facial temperatures correlate with chronic illnesses like diabetes and high blood pressure, and these can be detected using AI with thermal cameras. They highlight the potential of this technology [...]
Breakthrough in aging research: Blocking IL-11 extends lifespan and improves health in mice
In a recent study published in the journal Nature, a team of researchers used murine models and various pharmacological and genetic approaches to examine whether pro-inflammatory signaling involving interleukin (IL)-11, which activates signaling molecules such [...]
Promise for a universal influenza vaccine: Scientists validate theory using 1918 flu virus
New research led by Oregon Health & Science University reveals a promising approach to developing a universal influenza vaccine—a so-called "one and done" vaccine that confers lifetime immunity against an evolving virus. The study, [...]
New Projects Aim To Pioneer the Future of Neuroscience
One study will investigate the alterations in brain activity at the cellular level caused by psilocybin, the psychoactive substance found in “magic mushrooms.” How do neurons respond to the effects of magic mushrooms? What [...]
Decoding the Decline: Scientific Insights Into Long COVID’s Retreat
Research indicates a significant reduction in long COVID risk, largely due to vaccination and the virus’s evolution. The study analyzes data from over 441,000 veterans, showing lower rates of long COVID among vaccinated individuals compared [...]
Silicon Transformed: A Breakthrough in Laser Nanofabrication
A new method enables precise nanofabrication inside silicon using spatial light modulation and laser pulses, creating advanced nanostructures for potential use in electronics and photonics. Silicon, the cornerstone of modern electronics, photovoltaics, and photonics, [...]
Caught in the actinium: New research could help design better cancer treatments
The element actinium was first discovered at the turn of the 20th century, but even now, nearly 125 years later, researchers still don't have a good grasp on the metal's chemistry. That's because actinium [...]
Innovative Light-Controlled Drugs Could Revolutionize Neuropathic Pain Treatment
A team of researchers from the Institute for Bioengineering of Catalonia (IBEC) has developed light-activated derivatives of the anti-epileptic drug carbamazepine to treat neuropathic pain. Light can be harnessed to target drugs to specific [...]
Green Gold: Turning E-Waste Into a Treasure Trove of Rare Earth Metals
Scientists are developing a process inspired by nature that efficiently recovers europium from old fluorescent lamps. The approach could lead to the long-awaited recycling of rare earth metals. A small molecule that naturally serves [...]
Cambridge Study: AI Chatbots Have an “Empathy Gap,” and It Could Be Dangerous
A new study suggests a framework for “Child Safe AI” in response to recent incidents showing that many children perceive chatbots as quasi-human and reliable. A study has indicated that AI chatbots often exhibit [...]
Nanoparticle-based delivery system could offer treatment for diabetics with rare insulin allergy
Up to 3% of people with diabetes have an allergic reaction to insulin. A team at Forschungszentrum Jülich has now studied a method that could be used to deliver the active substance into the [...]
Nanorobot kills cancer cells in mice with hidden weapon
Researchers at Karolinska Institutet in Sweden have developed nanorobots that kill cancer cells in mice. The robot's weapon is hidden in a nanostructure and is exposed only in the tumor microenvironment, sparing healthy cells. [...]